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Abstract 
Introduction: Non-Alcoholic fatty liver disease (NAFLD) is the most common chronic liver 
condition in the U.S and is an emerging public health concern in adolescents. Risk factors for 
adolescent NAFLD remain largely unexamined.  
Aim: To investigate if demographic and dietary-related factors are linked with NAFLD in 
adolescents.  
Methods: Cross-sectional data from NHANES (2001-2006) ages 12-19 (n=4714) were analyzed. 
NAFLD was defined as >30 u/L ALT. Food Insecurity levels (child, adult, household), 
race/ethnicity, sex, BMI, and the Dietary Inflammatory Index (DII) were tested using 
multivariate binary logistic regression with elevated ALT (no, yes) as the dependent variable. 
Results: Risk for elevated ALT among Non-Hispanic Blacks was 1.25 times greater compared to 
Non-Hispanic Whites (95% CI 1.00-1.57). Higher DII quartiles (i.e., increasingly pro-
inflammatory) show a possible link with elevated ALT (e.g., Q2vsQ1: OR=1.23, 95% CI .95-
1.59; Q3vsQ1: OR=1.31, 95% CI 1.01-1.69; Q4vsQ1: OR=1.14 95% CI .88-1.48). Findings 
regarding food security were inconclusive. 
Conclusion: This study is the first report, to our knowledge, that Non-Hispanic Blacks might be 
at greater risk for adolescent NAFLD compared to Non-Hispanic Whites. Lack of an association 
with Hispanics is inconsistent with prior research in adults, however. Future research is 
suggested to understand underlying risk factors linked with disparate risk. A potential association 
with a pro-inflammatory diet also warrants further study. We posit that inconclusive results about 
food insecurity might due to lower rates of obesity, a known risk factor for NAFLD, in this 
vulnerable population. 
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1. Apply epidemiological methods to the breadth of settings and situations in public health 
practice 
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6. Discuss the means by which structural bias, social inequities and racism undermine health and 
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Introduction 
Overview. Non-Alcoholic Fatty Liver disease (NAFLD) is a chronic liver condition caused by 
excess accumulation of fat in the liver. NAFLD is the most common chronic liver disease in 
children and adults in industrialized countries and is associated with an increased risk of 
cardiovascular disease, type 2 diabetes (T2D), and liver-related morbidity (Alkhouri & Kay, 
2012). NAFLD can be divided into 2 subtypes: 1) Simple fatty liver disease, which is 
characterized by no inflammation or cell damage; and 2) Non-alcoholic steatohepatitis (NASH) 
where inflammation and cell damage do occur. The difficulty with NAFLD and NASH is the 
lack of identifiable symptoms, so they are considered silent diseases. While the direct cause of 
NAFLD is not known, it has been reported that prevalence increases with the occurrence of 
obesity, T2D, insulin resistance, and high lipid disorders. Pediatric NAFLD is thought to affect 
around 1 in 10 children in the United States and 34% of children with obesity (Draijer et al., 
2019). More research needed is to determine the lifestyle risk factors, improvements in screening 
methods, and potential treatment therapies. An unexplored potential risk factor is the association 
with food insecurity as a predictor for pediatric NAFLD due to its relationship with poor diet and 
obesity, which is what forms the research question of this thesis. Other variables that have been 
found to be potential factors such as race/ethnicity, c-reactive protein (CRP), the dietary 
inflammatory index (DII), body mass index (BMI) we examined for the cohort. 
 
Health Outcomes. NAFLD is characterized with metabolic syndrome (MetS) along with other 
entities such as diabetes, being overweight, high cholesterol, and high blood pressure (Kumar, 
Priyadarshi, & Anand, 2020). The two subtypes, nonalcoholic fatty liver (NAFL) and NASH are 
differentiated by the occurrence of inflammation or cell damage. The gold standard for NAFLD 
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diagnosis is through histology of the liver tissues, most recently utilizing the NAFLD activity 
score developed by the Pathology Committee of the NASH Clinical Research Network. The 
score is used to determine the amount of fat accumulation, inflammation, and fibrosis 
(Lindenmeyer & McCullough, 2018). To accurately diagnose NAFLD, all other potential causes 
of liver steatosis such as alcohol consumption, hemochromatosis, viral hepatitis, and certain 
hereditary disorders must be excluded (Chalasani, 2012). It is important to make a histological 
distinction between the subtypes because therapeutic interventions for treatment vary for each, 
and as the disease progress, those afflicted have increased risk of fibrosis, cirrhosis and end-stage 
liver disease (Lindenmeyer & McCullough, 2018). The spectrum of diagnosis ranges from 
simple steatosis (SS), to NASH, and then ultimately hepatocellular carcinoma (HCC). This 
progression is still incompletely defined as SS is now shown to be more progressive than 
originally believed. Along with the variants associates with MetS, some genetic polymorphisms 
have a significant impact on the progression (Kumar et al., 2020). 
 There have been many studies looking into the progression of NAFL versus NASH to 
better understand the connection between them. A 2006 study by Ekstedt found that NASH is 
associated with a reduced survival more than NAFL and death being most commonly cause by 
cardiovascular disease. This study also found that elevated liver enzymes such as Alanine 
Aminotransferase (ALT) and Aspartate Aminotransferase (AST) is a risk factor for developing 
end-stage liver disease (Ekstedt, 2006). Initially it was thought that NAFL could not progress to 
NASH, but a 2013 study found that, especially in the presence of risk factors, patients with 
NAFL could progress to NASH with fibrosis. Those with any degree of mild inflammation or 
fibrosis were at higher risk for progression than those with only liver fat build-up. Progression 
occurred in tandem with elevated ALT, higher weight gain, and higher diabetes incidence (Pais 
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et al., 2013). The final stage of NAFLD, HCC, is the most common type of primary liver cancer 
and is the fastest-rising cause of cancer-related deaths in the US. HCC occurs most often in those 
with chronic hepatitis C (HCV), hepatitis B (HBV), NAFLD, diabetes, or heavy alcohol drinkers. 
The incidence of HCC has been increasing in North America but decreasing in Japan and parts of 
China, which were traditionally high-risk regions (Kulik & El-Serag, 2019). A 2015 study by 
Kallwitz et al., found that this trend is likely due to higher rates of HCV, HBV, and NAFLD and 
that Hispanic Americans with HCV or NAFLD have a higher risk of progression to cirrhosis and 
HCC (Kallwitz et al., 2015).  
 NAFLD has long been considered a display of MetS in the liver. Diagnosis of MetS 
requires confirmation of 3 of the 5 following factors: obesity, hypertension, low HDL 
cholesterol, hypertriglyceridemia, and fasting hyperglycemia. Determination is made based on 
waist circumference over 102 cm for males and 88 for females, blood pressure over 135/85, 
fasting blood glucose over 100 mg/dl, HDL under 40 mg/dl in males and under 50 mg/dl in 
females, and triglycerides over 150 mg/dl (Sumner & Cowie, 2008). NADLF has been found to 
present clinical and laboratory data like that of diabetes and obesity, including insulin resistance, 
increased triglycerides, increased uric acid, and low HDL cholesterol (Marchesini et al., 2001). 
In 2003, Marchesini et al. documented that MetS was a high risk for NASH and that increasing 
prevalence of obesity and diabetes in the population would lead to a large risk of liver failure in 
the coming decades which is what has occurred (Marchesini et al. 2003). Many studies have 
strongly associated ALT with NAFLD and NAFLD is the common cause of unexplained mild 
ALT elevation (Liu, Que, Xu, & Peng, 2014). Liu et al. suggest that when elevated ALT is 
present without viral hepatitis or excessive alcohol consumption, NAFLD is the cause. 
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 Currently, NAFLD is known to be a risk factor with many diseases such as type 2 
diabetes mellitus (T2DM), cardiovascular disease (CVD), chronic kidney disease (CKD), 
polycystic ovarian syndrome, obstructive sleep apnea, psoriasis, osteoporosis, stroke, acute 
pancreatitis, and recently with sarcopenia (Kumar et al., 2020). NAFLD has also become the 
second most common indication for liver transplantation (LT) after chronic hepatitis C, with new 
LT waitlist registrants increasing by 170% from 2004-2013 (Lindenmeyer & McCullough, 
2018). NAFLD is both a cause in the development of T2DM, but also a consequence of pre-
existing T2DM. Two large meta-analyses confirmed this relationship, with 58% of NAFLD 
patients developing T2DM (Kumar et al., 2020; Musso, Gambino, Cassader, & Pagano, 2011). 
The risk of T2DM was found to be three times higher for patients with NASH versus SS and 
showed increased risk of NAFLD progression to NASH and HCC. Overall, the coexistence of 
diabetes and NAFLD in a patient increases risk of progression and complications related to both 
diseases. Increased risk of CVD has consistently been seen with studies showing increased 
carotid artery thickness, increased arterial stiffness, impaired flow of dilated blood vessels, and 
endothelial dysfunction ((Kumar et al., 2020). A 2016 study found that progression of NAFLD is 
associated with increased risk of subclinical carotid atherosclerosis (Sinn et al., 2016). Studies 
confirm the association of increase CVD prevalence, but more research is needed to determine 
the association of increased CVD mortality and if these associations are due to shared risk 
factors or NAFLD itself is and additional risk for CVD (Kumar et al., 2020). A 2014 meta-
analysis on 64,000 subjects found NAFLD was associated with a 2-fold increase in incident and 
prevalent CKD, with more progressive forms such as NAFL with fibrosis and NASH being more 
positively correlated with CKD in comparison to SS (Musso et al., 2014). The associations 
recognized in the review by Kumar et al. along with those by Lindenmeyer & McCullough 
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document the increasing risk and associations of NAFLD, with projections showing an ever-
increasing global impact.  
 Treatment of NAFLD includes working to treat the liver disease along with lifestyle 
modifications to help with the associated risk factors of diabetes, obesity, and hyperlipidemia. 
Chalasani et al. found that weight loss can reduce fat in the liver, inflammation and scarring and 
most clinicians are recommended to get patients to lose weight through healthy food choices and 
increase physical activity (Chalasani, 2012). Losing 3-5% of body weight can reduce fat in the 
liver and it was found that a low-calorie diet along with increased physical activity can improve 
NAFLD and NASH outcomes (Ahmed, Wong, & Harrison, 2015). It has also been seen that 
exercise alone, without weight loss, can improve NAFLD outcomes, with a combination of 
exercise, medication, and diet changes being the most effective (Oliviera, de Lima Sanches, de 
Abreu-Silva, & Marcadenti, 2016). Weight reduction through bariatric surgery has shown 
benefits for NAFLD patients as well. A medication considered for treatment is metformin which 
is commonly prescribed for diabetic patients but studies on the effectiveness of metformin for 
NAFLD have shown mixed results (Sao & Aronow, 2018). Generally, there is no standard 
pharmacological treatment, with the standard options being to target weight loss through diet 
changes and physical activity. This is most applicable for those with NASH as it has been found 
that a loss of >7% body fast is associated with disease regression. The main difficulty in 
treatment is implementing the lifestyle changes in clinical care and the daily life of the patient 
(Romero-Gomez, Zelber-Sagi & Trenell, 2017). With more big data analyses being conducted on 
this topic, the true global disease burden can be seen with the increase in progression, associated 
conditions, and need for enhanced treatment and prevention options.  
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Epidemiology. The spread of NAFLD can be seen worldwide but the exact incidence and 
prevalence are unknown due to the lack of accuracy in the noninvasive markers related to the 
condition. Liver biopsy for histology is invasive and expensive so noninvasive measures such as 
liver-associated tests, imaging, or spectroscopy methods have been considered (Ong, & Zobair, 
2007). Community surveys have utilized ultrasonography or proton NMR spectroscopy whereas 
studies based on elevated liver enzymes were found to systematically underestimated the true 
prevalence. Overall, global prevalence of NAFLD is currently estimated to be 24% as of 2018 
(Younossi et al., 2018). Through data from the National Health and Nutrition Examination 
Surveys (NHANES) from 1988 to 2008, it has been seen that NAFLD prevalence has doubled in 
the US from 46.8% to 75.1% of chronic liver disease cases. It is projected that this will increase 
by 21% by 2030, leading to an overall prevalence of 33.5% in the general population (Kumar et 
al., 2020).  
 Globally, the highest rates are from South America (31%), the Middle East (32%), Asia 
(27%), the USA (24%), and Europe (23%). The least common incidence is reported in Africa 
with 14%. A 2016 meta-analysis conducted by Younossi et al. determined NAFLD prevalence in 
the USA through ultrasonography, Fatty Liver Index (FLI), and the International Classification 
of Diseases (ICD). The findings followed that disease diagnosis solely based on ICD or blood 
testing led to underreporting. This study found that prevalence varied by ethnicity, with Hispanic 
American having the highest rates, followed by Americans of European descent and African 
Americans. While unconfirmed, this disparity is thought to be due to socioeconomic disparities, 
along with the possibility of genetic factors and presence of MetS. This finding is supported 
through many previous studies but contradicts the findings of higher obesity and hypertension in 
African American patients and Serif et al., found that there is a concern that the disease burden 
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of NAFLD on the African American population is actually underestimated (Sherif et al., 2016). 
Another assessment of NHANES data found that NAFLD posed a significantly higher risk in 
black adolescents but for adults, education was inversely related (Jaradat, 2017). A 2017 study 
found NAFLD prevalence in the US as 30% with 10.3% of these cases having advanced fibrosis. 
This study defined NAFLD as subjects having a US Fatty Liver Index (USFLI) greater than 30 
which has been shown to correlate with NAFLD diagnosed through ultrasound. It was found that 
subject with NAFLD were more likely to have higher ALT and AST (Le et al., 2017).  
 NAFLD without the presence of obesity is termed “lean NAFLD”. This was initially 
described in Asian populations and believed to be more benign than NAFLD, but studies have 
found that patients with lean NAFLD have impaired insulin sensitivity, increased cardiovascular 
risk, and increased liver fat levels. A study by Fracanzani et al. in 2011 found that 55% of 
patients without obesity did have NASH and fibrosis and a study by Leung et al. in 2017 found 
that 51.9% of obese versus 43.5% of non-obese patients had NASH suggesting that obesity 
might not be as associated with fibrosis progression. Since it is harder to diagnose and identify 
risk factors for those with lean NAFLD, further research is needed into the topic (Younossi et al., 
2018). 
  
Pediatric NAFLD. Pediatric NAFLD is defined as chronic hepatic steatosis in children when no 
occurring with genetic/metabolic disorders, infections, alcohol consumption or malnutrition. In 
most children, NAFLD is associated with insulin resistance, obesity, high triglycerides, and low 
HDL cholesterol levels (Vos et al., 2017). As obesity in children increased worldwide, so has the 
prevalence rates of pediatric NAFLD. In the general pediatric population NAFLD presents at 
7.6% while in the obese pediatric population it is 34.2% (Anderson et al., 2015). It has been seen 
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that 66% of children with biopsy proven NAFLD had one or more metabolic risk factors, with 
T2DM and insulin resistance having the strongest link (Draijer et al., 2019). Children with 
NAFLD are at high risk of progressing to end-stage liver disease and cases of liver 
transplantation (Alkhouri et al., 2016) While this public health problem is severely increasing, 
there is a large lack of research in the area of pediatric NAFLD and many unknowns. 
 From a special report by Hatton et al. (2018): “Pediatric NAFLD has previously been 
ascribed to three broad histological types: (1) Centrilobular steatosis, ballooning degeneration 
and inflammation with perisinusoidal fibrosis; (2) periportal inflammation and steatosis with 
portal fibrosis; and (3) overlap between 1 and 2.” (p. 961). Type 2 is more common in children 
than adult NASH but there is little known on why or how NASH is different between the 
populations. It is unknown how to stratify children into risk groups for interventions based on 
related diseases such as CVD and diabetes and it is thought that pediatric NASH has a different 
immune process than adult NASH, but it is not well understood. The direct cause of pediatric 
versus adult NAFLD is different and further research is needed to determine appropriate 
diagnosis methods and treatment. It has been found that prenatal and postnatal factors contribute 
to the development of pediatric NAFLD, but the etiology and pathophysiology are not well 
defined (Hatton et al., 2018). A 2013 study found support for the racial/ethnic differences in the 
link between MetS and NAFLD in adolescent populations. It found that the prevalence of MetS 
in was 10.6% in Hispanics, 8.4% in Whites and 4.2% in Blacks and this was paralleled with 
13.7% in Hispanics, 8.6% in Whites and 5.2% in blacks for elevated ALT. ALT was defined as 
the best marker for NAFLD as an alternative to biopsy as ALT had a .92 sensitivity to 
identifying fatty-fibrotic findings on ultrasound. This study also found that adolescents with 
MetS with 7.8 times more likely to have elevated ALT (DeBoer et al., 2013). The use of ALT as 
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a marker for pediatric NAFLD has been supported by the North American Society for Pediatric 
Gastroenterology, Hepatology & Nutrition in a clinical practice guideline released in 2017. The 
ALT assay has been standardized across facilities but the cut-off points for normal ALT levels 
has not. In the US, the cut-off has been defined as 22 mg/dl for girls and 26 mg/dl for boys while 
in Canada, the upper limit for normal ALT was 30 mg/dl for children 1-12 years old and 24 
mg/dl for children 13-19 years old. NASH was found to be associated with ALT greater than 8- 
U/L (Vos et al., 2017).  
 Children with NAFLD and fibrosis are at higher risk of long-term liver complications due 
to their life span and as diagnosis is difficult without biopsy and treatment is limited to lifestyle 
interventions, the pediatric NAFLD population is at very high risk for complications. The ideal 
solution is obesity prevention early on, further research into this specific population, and 
increased awareness about this growing public health issue (Draijer et al, 2019). The pediatric 
obesity rate has risen from 5% to 16.9% from 1960 to 2010 and since weight gain during 
childhood carries a higher risk of NAFLD than weight gain in adulthood, risk of progressive 
NAFLD such as fibrosis, cirrhosis, HCC, end-stage liver disease, and liver-related death are 
increased (Younossi et al., 2018).  
 Even though pediatric NAFLD has such high prevalence and poor outcomes, it remains 
under-studied and under-recognized, allowing this trend to continue to increase for the 
foreseeable future. There are unmet needs in the areas of screening, diagnosis, treatment, and 
awareness. For those whom on the extreme end of the obesity spectrum, there are no non-
surgical options and there is a lack of collaboration between clinical specialties and targeted 
therapeutic interventions that could improve patient outcomes (Temple et al., 2016). More 
research is needed to find novel biomarkers and therapeutic agents to avoid the current risk of 
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long-term morbidity. The pediatric population is more vulnerable to genetic and environment 
factors so further research is also needed into the perinatal and postnatal stressors that increase 
risk of NAFLD onset (Goldner & Lavine, 2020). Dietary factors have been found to be 
associated with pediatric NAFLD and a study conducted in Korea found that children with 
suspected NAFLD were found to have elevated urinary sodium levels and elevated cholesterol 
intake (Kim & Lee, 2020). This is an area for further research to be able to best determine 
preventive dietary measures. In Dutch hospitals a survey was conducted to determine pediatric 
NAFLD screening practices and found that while widely performed, there is no uniform protocol 
to follow (Draijer et al., 2020). Overall, despite the high prevalence and serious complications, 
pediatric NAFLD is not as widely researched as adult onset NAFLD and leaves room for further 
exploration. 
 
Food Insecurity. As defined by the US Department of Agriculture (USDA), food security (FS) 
is defined as a household always having access to enough food for all members of the household 
to lead an active, healthy lifestyle. Food insecurity is defined as households that were uncertain 
of having or being unable to get enough food at times due to lack of money or other resources. 
Low food security is defined as households getting enough food to avoid substantially disrupting 
eating patterns or food intake by use of coping strategies such as a less varied diet, a food 
assistance program, or emergency food from a food pantry. Very low food security is defined as 
households that had a disruption of normal eating patterns for one or more member of the house 
along with reduced food intake due to lack of money or other resources. In 2018, 11.1% of 
households were food insecure, 6.8% were low food security and 4.3% were very low food 
security at some time during the year. These values are all lower than the food insecurity figures 
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for 2017 (Coleman-Jensen et al., 2019). Food insecurity affects 35% of low-income US 
households and has been associated with increased risk of diabetes, hypertension, obesity, and 
CVD (Golovaty et al., 2020). While these conditions have been shown to be strongly linked to 
NAFLD, there has been only one study looking into the correlation of food insecurity and 
NAFLD risk. The 2020 study by Golovaty et al. examined food insecurity as an independent risk 
factor for NAFLD in low-income adults. It was found that 29% of adults were food insecure and 
that food insecure adults were more likely to have NAFLD and advanced fibrosis than adults 
who were food secure (Golovaty et al., 2020). This is a huge area of potential research to further 
our understanding of the risk factors associated with NAFLD and improve upon 
recommendations for intervention and treatment. 
 
Systems Thinking. NAFLD is the most common form of chronic liver disease and is likely to 
become the leading cause of liver failure and liver transplantations in the pediatric populations. 
This disease is widespread and highly interconnected with other MetS disorders such as obesity, 
diabetes, and CVD. The main issue in the area of pediatric NAFLD is the lack of research. 
Currently, the main treatment option is weight loss through diet and exercise. If more research is 
conducted into the etiology and pathophysiology, the is potential for alternative diagnostic tests, 
more interventions, better treatment options, and more awareness about the associated 
conditions. The increase in pediatric cases is tied to the increase in obesity worldwide. The 
obesity epidemic is due to the current food habits and food available to people around the world. 
If people are more food secure (having access to fresh, health, inexpensive options regularly), 
then there is no need to purchase fast food or other unhealthy options. This is impacted by the 
socioeconomic levels of families, the local environment they live in and access to care, and 
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knowledge on how to be and stay healthy. For children, funding and implementation of the 
national school breakfast, lunch, summer programs could heavily impact food security. 
Government policy based on the findings of the scientific community regarding food security, 
food deserts, obesity, NAFLD, and risk factors could drastically change the obesity epidemic. If 
policy could be enacted for better regulations on fast food companies and increasing the number 
of supermarkets with fresh food in areas that need it. For people who need assistance, policy 
impacts the availability of Supplemental Nutrition Assistance Program (SNAP), formerly known 
as food stamps, and stipends. Policy can also impact the funding that goes into research and the 
funding that goes into other stakeholders such as hospitals, physicians, local health departments, 
and insurance companies. NAFLD has many comorbidities which impact these stakeholders 
when treatment is needed for NAFLD, CVD, and diabetes. With the increase in association for 
liver transplantation, hospitals, physicians, insurance companies, and the overall cost on the 
healthcare system increases. If the initial risk factors can be intervened upon, then all the 
following procedures and costs could be avoided. 
 The public health issue of rising pediatric NAFLD is not a simple problem to treat with a 
one-step solution, but a complex issue that ties into many stakeholders in the healthcare system. 
By increasing awareness on the large impact of the disease, it is more likely that particular 
research will be conducted in the unmet areas, better policy can be enforced to improve structural 
and environmental issues, and a more holistic approach can be taken to try and reduce the global 
burden of this disease. 
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Prevention, Diagnosis, and Treatment of Emerging Incidence of NAFLD in Adolescents 
 
Figure 1. Systems Thinking Map 
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Statement of the Problem. There is very little understanding of why certain people get NAFLD 
and why in some people this condition is exacerbated to levels of extreme cirrhosis. There is also 
very little known about the symptoms of NAFLD, making it very difficult to identify at-risk 
populations. NAFLD has become increasingly prevalent in the pediatric population. Previous 
thesis work identified that NAFLD is more prominent in black adolescents and in adults with 
less than a college degree (Jaradat, 2017). This thesis also found that the three-fold greater 
prevalence of elevated uric acid in both age groups, which warrants further research and might 
have translational value for screening for liver disease. By adding the risk factor of food 
insecurity into this study, there is a likelihood to more deeply understand a possible underlying 
factor associated with a racial difference. 
 Rates of pediatric NAFLD are currently following the rising rates in childhood obesity, 
which is a well-established public health problem. Many studies have found that food insecurity 
is tied to obesity. If food insecurity is identified as a social determinant of NAFLD, the findings 
could add to the growing evidence about the harms of food insecurity and shape future public 
policies to increase awareness and promote improvements, especially in highly impacted 
populations. If correlations are found, then there is a high possibility that structural bias, social 
inequities, and racism could be tied to the food insecurity predictors and systems thinking will 
need to be applied to the findings to understand the interactions of these aspects, and how we can 
use these findings to potentially reduce prevalence of pediatric NAFLD. As a disease of serious 
long-term consequences, new causative information about NAFLD is important, especially given 
the lack of studies present on pediatric NAFLD.   
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Methods 
Sample. All data analysis was conducted using the continuous 2001-2006 NHANES data set. 
NHANES is a population-based surveillance program conducted by the National Center for 
Health Statistics (NCHC) that has been continuously conducted since 1999. (Please note: Dr. 
Swede has received blanket approval from the UCH IRB for use of NHANES datasets under 
Exempt Status, i.e., non-human subjects research, for use in student and faculty research 
projects.) The survey includes a questionnaire, an interview, an at-home medical examination, 
and a mobile center for laboratory tests. The data includes a variety of variables related to 
physical and environmental conditions that tie to prevalent health conditions in the U.S. For this 
analysis, participants were included if they were 12-19 years old (n=7078) and had the NAFLD 
indicator marker (ALT) documented. Pregnant females were excluded per previously conducted 
studies examining ALT and NAFLD (Umehara, 2018). The study sample (n=4714) consists of 
males (n=2412) and non-pregnant females (n=2302) with valid ALT results, n=3921 for normal 
ALT and n=793 for elevated ALT. 
Variables. In the existing dataset, NAFLD was defined by two established blood markers, ALT 
and AST. Per the NASPGHAN clinical practice guidelines, ALT is the recommended standard 
marker for NAFLD (Vos et al., 2017). In this study, normal ALT was defined as lower to equal 
to 30 U/L and elevated ALT was defined as greater than 30 U/L. As the NASPGHAN guidelines 
had discrepancies for US versus Canadian recommendations, we followed thresholds as 
described in DeBoer et al. (2013). Several independent variables were examined in this study to 
ensure no selection bias along with no sample bias as evident in Table 2. Demographic 
characteristics examined were sex and race/ethnicity. Education could not be examined due to 
lack of data in the selected study cohort. 
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 C-reactive protein (CRP) is an inflammatory marker and has been linked to CVD and 
obesity (Barinas-Mitchell et al., 2001). The original CRP data was sorted as low risk if <1 mg/L, 
average risk between 1 and 3 and high risk above 3 mg/L. CRP value >10 mg/L were excluded 
as it is indicative of an acute infection. This data was transformed into quartiles of <.09 (Q1), 
.09-.23 (Q2), .23-.53 (Q3) and >.52 (Q4) to allow for better population distribution analysis. 
BMI was categorized as underweight (<18.5), normal (18.5-24.9), overweight (25.0-29.9), obese 
(30.0-34.9) and morbidly obese (>35) per CDC guidelines.  
Dietary inflammatory Index (DII) is based on 8 pro-inflammatory and 8 anti-
inflammatory components to assess the inflammatory potential of dietary factors (Kanauchi et 
al., 2019). DII was developed to provide a quantitative means for assessing the role of diet in 
relation to health outcomes designed to be applicable across all human studies with 
adequate dietary assessment. DII is a continuous variable which was transformed into quartiles 
for population comparison analysis with the 1st to 4th quartile going from less to more 
proinflammatory (Hébert et al., 2019). 
 NHANES has created summary variables that characterize food insecurity using U.S. 
Household Food Security Survey Module split into household, adult, and child: 
Household: whether the statement was often true, sometimes true, or never true for (you/your 
household) in the last 12 months 
1) “(I/We) worried whether (my/our) food would run out before (I/we) got money to 
buy more.” Was that often true, sometimes true, or never true for (you/your household) in 
the last 12 months? 
2) “The food that (I/we) bought just didn’t last, and (I/we) didn’t have money to get 
more.” Was that often, sometimes, or never true for (you/your household) in the last 12 
months? 
3) “(I/we) couldn’t afford to eat balanced meals.” Was that often, sometimes, or 
never true for (you/your household) in the last 12 months? 
Adult:  
1) In the last 12 months, since last (name of current month), did (you/you or other 
adults in your household) ever cut the size of your meals or skip meals because there 
wasn't enough money for food? 
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2) [IF YES ABOVE, ASK] How often did this happen—almost every month, some 
months but not every month, or in only 1 or 2 months? 
3) In the last 12 months, did you ever eat less than you felt you should because there 
wasn't enough money for food? 
4) In the last 12 months, were you every hungry but didn't eat because there wasn't 
enough money for food? 
5) In the last 12 months, did you lose weight because there wasn't enough money for 
food? 
6) In the last 12 months, did (you/you or other adults in your household) ever not eat 
for a whole day because there wasn't enough money for food? 
7) [IF YES ABOVE, ASK] How often did this happen—almost every month, some 
months but not every month, or in only 1 or 2 months? 
Child:  
1) “(I/we) relied on only a few kinds of low-cost food to feed (my/our) child/the 
children) because (I was/we were) running out of money to buy food.” Was that often, 
sometimes, or never true for (you/your household) in the last 12 months? 
2) “(I/We) couldn’t feed (my/our) child/the children) a balanced meal, because 
(I/we) couldn’t afford that.” Was that often, sometimes, or never true for (you/your 
household) in the last 12 months? 
3) "(My/Our child was/The children were) not eating enough because (I/we) just 
couldn't afford enough food." Was that often, sometimes, or never true for (you/your 
household) in the last 12 months? 
4) In the last 12 months, since (current month) of last year, did you ever cut the size 
of (your child's/any of the children's) meals because there wasn't enough money for food? 
5) In the last 12 months, did (CHILD’S NAME/any of the children) ever skip meals 
because there wasn't enough money for food? 
6) [IF YES ABOVE ASK] How often did this happen—almost every month, some 
months but not every month, or in only 1 or 2 months? 
7) In the last 12 months, (was your child/were the children) ever hungry but you just 
couldn't afford more food? 
8) In the last 12 months, did (your child/any of the children) ever not eat for a whole 
day because there wasn't enough money for food? 
Both adult and household food security were defined per USDA regulations as fully food 
secure, marginal food security, low food security, or very low food security. The household 
measure uses all 18 items, or 10 items for households without children, consistent with the CPS 
categorical measure. The four categories created for household food security are: food secure, 
marginally food secure, food insecure without hunger, and food insecure with hunger. The adult 
measure uses 10 items and categories are the same as those used for the household measure. For 
adult-only households, the household and adult measures are identical (NHANES 2001-2002, 
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2004). For this analysis, the categories correspond to full food security, marginal, low and very 
low food security respectively in the attached tables. 
The child measure categorization is based upon “Measuring Children’s Food Security in 
U.S. Households, 1995-99” (ERS research report) which uses the 8 child-referenced items to 
classify households into two categories, no or insufficient evidence of hunger versus clear 
evidence of hunger. In order to keep consistent with the household and adult measures, 
NHANES data are grouped into four categories. The first category in the ERS report is separated 
into three categories 1) food quantity and quality unaffected, 2) marginally food secure, and 3) 
food insecure without hunger. The most severe category is scored the same as that in the ERS 
report labeled “child food insecure with hunger” (NHANES 2001-2002, 2004). For the 2003-
2006 surveys, this was updated to the categories 1) food quality & quantity unaffected, 2) 
reduced food quality or quantity, 3) reduced food quality and quantity, and 4) severely reduced 
food quality and quantity (National Health and Nutrition Examination Survey 2003-2004, 2007).  
 Statistical analysis was conducted with Statistical Package for the Social Sciences (SPSS) 
version 26. Descriptive analyses, t-Tests for continuous dependent values and Chi-Square tests 
for categorical variables, were conducted to examine the prevalence of study variables by 
NAFLD status. Univariate and multivariate logistic regression was conducted to find which 
variables predict NAFLD (yes, no) in the pediatric population with a 95% confidence interval. In 
keeping with the recent policy from the American Statistical Association, we will report specific 
p-values for each test, and not use a threshold cut-point. 
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Results 
Table 1 describes the demographic and clinicopathological characteristics of our study 
population. The study sample (n=4714) consists of males (n=2412) and non-pregnant females 
(n=2302) with valid ALT results, n=3921 for normal ALT and n=793 for elevated ALT. The 
overall prevalence of NAFLD as defined by elevated ALT >30 U/L was 793/3921 or 20.22%. 
Prevalence was similar across sexes with 17.2% of males and 16.5% of females showing 
elevated ALT (p=.521). Prevalence was varied across race/ethnicity with Non-Hispanic Whites 
(NHW) having a much lower prevalence, 15.0%, than Non-Hispanic Blacks (NHB),18.8%, the 
Hispanic population at 16.3% and other races/ethnicities at 17.3% (p=.055). Within the CRP 
quartiles high ALT ranges from 16.5% (Q2) to 17.4% (Q4) with no clear pattern (p=.785). 
Similarly, with BMI, 16.5% of the underweight, 17.0% of normal weight, 16.4% overweight, 
18.3% of obese, and 14.9% of morbidly obese population showed elevated ALT levels (p=.831). 
DII results across quartiles were 15.4% (Q1), 17.1% (Q2), 17.5% (Q3), and 16.9% (Q4) for 
elevated ALT (p=.576). For child food security, elevated ALT levels were found at 17.1%, 
14.7%, 17.4%, and 20.6% for Unaffected, Reduced Quality or Quantity, Reduced Quality and 
Quantity, and Severely Reduced Quality and Quantity of FS, respectively (p=.549). Adult and 
household FS showed similar elevated ALT values per level of food security. Adult FS had 
elevated ALT in 16.5% of the fully food secure, 18.2% in marginally food secure, 16.3% in low 
food security, and 18.7% in the very low food security populations (p=.568). Household food 
security was the final characteristic analyzed, with 16.4%, 19.1%, 16.6% and 18.1% of the full, 
marginal, low, and very low FS populations respectively displaying elevated ALT.  
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Table 2 describes the same demographic and clinicopathological characteristics of our study 
population as Table 1 but is comparing the populations of those included in the sample (n=4714) 
versus those who were excluded (n=2364) such as pregnant females or those with no ALT 
values. This was done to ensure there was no selection or sample bias in defining the sample 
cohort. Of the total 7078, 4714 samples (66.6%) were included and 2364 (33.3%) were excluded. 
Across all the variables that were examined, the included samples were fairly representative in 
comparison to the excluded samples, for example, included males were 51.2% of the cohort 
compare to 47.8% excluded. The largest discrepancies were in CRP and BMI. For CRP, the 
breakdown between the quartiles was 60.7%, 14.1%, 8.8% and 7.7% included versus 51.1%, 
12.9%, 9.8%, and 8.8% excluded for Q1 to Q4 respectively. In the BMI categories, the included 
sample breakdown was 14.3%, 54.4%, 18.2%, 7.6%, and 5.5% for the underweight to morbidly 
obese population respectively. This is compared to the excluded breakdown of 12.6%, 52.2%, 
17.5%, 10.5%, and 7.2%. For a majority of the samples the included participants were 
representative respective to the excluded cohort, the largest variation being a 9.6% difference in 
the Q1 selection sample for CRP. 
Table 3 stratifies the study population by race/ethnicity. For sex, Non-Hispanic Black rates of 
elevated ALT were 18.7% for males and 18.9% for females (p=.893). In CRP, Non-Hispanic 
Black elevated ALT was 19.8%, 14.9%, 16%, and 20% in quartiles 1 to 4, respectively. Non-
Hispanic Black elevated ALT rates for BMI were found to be 18.7% for underweight, 18.9% for 
normal weight, 20.7% for overweight, 18.9% for obese, and 13.1% for morbidly obese 
populations. Across DII quartiles, Non-Hispanic Black elevated ALT was 18.3%, 20.6%, 16.7%, 
and 19.5%. For child food security, prevalence of elevated ALT in the severely reduced quality 
and quantity was the highest of all categories within Non-Hispanic Blacks at 22%. Adult food 
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security elevated ALT levels for Non-Hispanic Blacks were 18.6%, 20.3%, 17.8% and 21.6% for 
full, marginal, low, and very low food security populations. Household food security elevated 
ALT levels for Non-Hispanic Blacks were 18.4%, 20.8%, 19.6% and 20.5% for full, marginal, 
low, and very low food security populations. 
Table 4 presents results of univariate and multivariate models of a binary logistic regression on 
all the variables previously examined. Non-Hispanic Black participants were 1.31 times more 
likely (95% CI 1.07-1.59) to have elevated ALT compared to Non-Hispanic Whites in the 
univariate model and 1.25 times more likely (95% CI 1.00-1.57) in the multivariate model. 
Increased DII score as stratified by quartile (i.e., increasingly pro-inflammatory) were linked to 
elevated risk of elevated ALT (e.g., Q2vs Q1: OR=1.23, 95% CI .95-1.59; and, Q3 vs Q1, 
OR=1.31, 95% CI 1.01-1.69.) Adolescents characterized as having reduced quality or quantity of 
food appeared less likely to have elevated ALT compared to children rated as unaffected by 
insecurity (OR=0.63, 95% CI 0.37-1.09). Similarly, those characterized on the adult scale as 
being marginally insecure were at a possible reduced risk compared to those fully secure 
(OR=0.58, 95% CI 0.22-1.51). In contrast, using the household level assessment, adolescents 
marginally food insecure were at possible increased risk for elevated ALT compared to the fully 
secure (OR=2.08, 95% CI 0.80-5.41). 
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Discussion 
Prevalence of NAFLD. The prevalence of elevated ALT in the overall cohort was 20.22%. This 
did not vary noticeably for any variable except for race ethnicity. Non-Hispanic Blacks had the 
highest elevated ALT of 18.8% in comparison to Non-Hispanic Blacks at 15.0%, Hispanics at 
16.3% and other at 17.3% (p=.055). Elevated ALT was indicated as levels higher than 30 U/L 
but in the future, this study could be modified to the updated cut-offs of 22 mg/dl for girls and 26 
mg/dl based on the clinical practice guideline released in 2017 as this could have an impact on 
the prevalence proportions for boys. As different studies use a variety of cut-off levels, 22 and 26 
could be reference lab values for evaluating elevated liver enzymes due to medical conditions 
like viral hepatitis, autoimmune hepatitis, obstructive liver disease and others. However, these 
levels are for clinical evaluation, in this study we are using epidemiological evaluation. Some 
epidemiological studies used 40 and got similar results (Vos et al., 2017).  
Food Insecurity and NAFLD. Estimated risks associated with Food Security were inconclusive 
and are therefore suggestive of inconsistency across the three measures. Among the child and 
adult assessments of food security, adolescents in the “reduced quality or quantity” or “marginal” 
food security respectively appeared less likely to have elevated ALT compared to those rated as 
fully food secure. In contrast, using the household level assessment, adolescents categorized as 
marginally food insecure were at possible increased risk for elevated ALT compared to the fully 
secure. While all food security analyses were not convincing due to lack of statistical 
significance, unravelling contrasting trends might be explained by more sophisticated analyses 
examining links among variables, such as factor analysis or structural equation modeling. 
Alternatively, it is possible that the impact of insecurity on NAFLD risk is a longer-term risk 
factor that might be revealed in prospective studies. This possibility in adolescents is consistent 
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with prior studies in adults linking food insecurity to the MetS and obesity, both of which have 
been linked to NAFLD. For example, Golovaty et al. reported a relationship between low-
income adults and NAFLD. Golovaty et al. found that the dose-response relation between 
severity of food security and NAFLD in adults was comparable to trends with obesity and 
diabetes. Further research in the pediatric cohort could be done to investigate a similar dose-
response relationship. An alternate explanation offered by Golovaty et al. was that worsened 
health status (NAFLD) causes food insecurity which is another area for future research. 
Regardless of the direction of the relationship between food security and NAFLD, further 
investigation is needed as these findings could impact potential NAFLD interventions and policy 
for low-income and food-insecure households. 
Race/Ethnicity and NAFLD. Non-Hispanic Black adolescents had a 25% increased likelihood 
of elevated ALT risk compared to Non-Hispanic whites. This effect is supported by the 
observation that Non-Hispanic Blacks had the highest prevalence of overweight/obesity (20.7%). 
We observed no increased risk in Hispanics compared to White adolescents which is inconsistent 
with prior research in race among adults. Our null finding for the pediatric population is novel, 
and further clarifying research is suggested to determine if risks for children and adults differ.  
Metabolic Factors and NAFLD. While CRP and BMI, have been known as metabolic 
indicators of diabetes and obesity, there were no significant findings when compared to elevated 
ALT for prevalence. Increased DII score, however, was linked to elevated risk of elevated ALT, 
which might find indirect support in a 2019 study found that change in diet improved intestinal 
permeability in patients with NAFLD and patients with lower diet adherence had higher values 
of DII (Biolato et al., 2019).  
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Strengths and Limitations. This study was conducted on a large validated sample which is 
nationally representative but there were several limitations. Per the data presented in Table 2, the 
sample selection was representative when compared to those excluded so there is minimal bias. 
As this was a cross-sectional study, we cannot point to data significance as causation, only 
correlation. Since food insecurity is a novel variable in association with NAFLD, this leaves 
room for further, more discrete investigation. Further limitations were lack of data for every 
variable investigated due to the age range limitations. This is justified as there is a large need for 
specific inquiry into pediatric NAFLD versus adult NAFLD. Also, the cut-offs for ALT were 
much higher than the current recommended ranges as a previous studies cut-off was utilized to 
be better able to compare the findings. Since the data sampled was 2001-2006, this could be 
recreated with more recent data with the most up-to-date ALT cut-offs.  
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Conclusion 
 In a cross-sectional study of US adolescents (12-19), we found that NAFLD prevalence 
was increased somewhat in Non-Hispanic Blacks (18.8%) in comparison to Non-Hispanic 
Whites (15.0%), which was supported by an observation of a 25% increased risk for elevated 
ALT in multivariate logistic regression. A pro-inflammatory diet appears to be a risk factor for 
elevated ALT in adolescents. With the inconsistency in linking NAFLD with food insecurity, we 
posit that this early risk factor might contribute to adult onset of this disease. Future studies are 
suggested to identify underlying factors linked to race that would pre-dispose adolescent onset of 
NAFLD. Further, we suggest that retrospective cohort analyses of early-life food insecurity 
might reveal a connection to adult onset NAFLD.  In general, more work is required to 
understanding the causes of adolescent onset NAFLD so that public health interventions and 
policies can be developed to stem this emerging epidemic. 
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Table 1 Demographics and Clinicopathological Factors of participants age 12-19 by ALT status in 
NHANES 2001-06 (n=4714) 
 Normal 
n=3921 
High 
n=793 
 
p-value 
Sex 
Male (n= 2412) 
Female (n=2302) 
 
 
1998 (82.8%) 
1923 (83.5%) 
 
414 (17.2%) 
379 (16.5%) .521 
Race/Ethnicity 
Non-Hispanic White (n=1329) 
Non-Hispanic Black (n=1571) 
Hispanic (n=1629) 
Other (n=185) 
 
 
1129 (85.0%) 
1276 (81.2%) 
1363 (83.7%) 
153 (82.7%) 
 
200 (15.0%) 
295 (18.8%) 
266 (16.3%) 
32 (17.3%) 
.055 
CRP1 (n=4304) 
Q1 [<.09] 
Q2 [.09-.23] 
Q3 [.23-.52] 
Q4 [>.52] 
 
 
2370 (82.9%) 
556 (83.5%) 
346 (83.2%) 
299 (82.6%) 
 
490 (17.1%) 
110 (16.5%) 
70 (16.8%) 
63 (17.4%) 
.785 
BMI2 (n=4620) 
Underweight [<18.5] 
Normal [18.5-24.9] 
Overweight [25.0-29.9] 
Obese [30.0-34.9] 
Morbidly Obese [>35.0] 
 
 
552 (83.5%) 
2086 (83.0%) 
703 (83.6%) 
285 (81.7%) 
217 (85.1%) 
 
109 (16.5%) 
428 (17.0%) 
138 (16.4%) 
64 (18.3%) 
38 (14.9%) 
.831 
DII3 (n=4504) 
Q1 [< -.82] 
Q2 [-.82-.32] 
Q3 [.32-1.25] 
Q4 [>1.25] 
 
 
854 (84.6%) 
958 (82.9%) 
937 (82.5%) 
1000 (83.1%) 
 
155 (15.4%) 
197 (17.1%) 
199 (17.5%) 
204 (16.9%) 
.576 
Food Security4 – Child (n=4022) 
Unaffected 
Reduced Quality or Quantity 
Reduced Quality and Quantity 
Severely Reduced Quality and Quantity 
 
 
2484 (82.9%) 
255 (85.3%) 
517 (82.6%) 
81 (79.4%) 
 
511 (17.1%) 
44 (14.7%) 
109 (17.4%) 
21 (20.6%) 
.549 
Food Security4 – Adult (n=4495) 
Full 
Marginal 
Low 
Very Low 
 
 
2479 (83.5%) 
481 (81.8%) 
462 (83.7%) 
314 (81.3%) 
 
490 (16.5%) 
107 (18.2%) 
90 (16.3%) 
72 (18.7%) 
.568 
Food Security4 – Household (n=4495) 
Full 
Marginal 
Low 
Very Low 
 
2449 (83.6%) 
382 (80.9%) 
579 (83.4%) 
326 (81.9%) 
 
482 (16.4%) 
90 (19.1%) 
115 (16.6%) 
72 (18.1%) 
.481 
1 C-reactive protein (CRP) is an inflammatory marker and has been linked to CVD and obesity (Barinas-Mitchell et al., 2001) 
2 Body-mass Index (BMI) was categorized per CDC guidelines 
3 Dietary inflammatory Index (DII) is based on 8 pro-inflammatory and 8 anti-inflammatory components to assess the inflammatory 
potential of dietary factors to provide a quantitative means for assessing the role of diet in relation to health outcomes (Kanauchi et al., 
2019) 
4 Food security was assessed using the US Food Security Survey Module (US FSSM). For further specifications see Methods (p. 15)  
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Table 2 Comparison of Included (n=4714) versus Excluded (n=2364) Participants age 12-19 
NHANES 2001-06 (n=7078) 
 Included 
n=4714 
Excluded 
n=2364 
 
p-value 
Sex 
Male (n= 2412) 
Female (n=2302) 
 
 
2412 (51.2%) 
2302 (48.8%) 
 
1129 (47.8%) 
1235 (52.2%) .007 
Race/Ethnicity 
Non-Hispanic White 
Non-Hispanic Black 
Hispanic 
Other 
 
 
1329 (28.2%) 
1571 (33.3%) 
1629 (34.6%) 
185 (3.9%) 
 
615 (26.0%) 
794 (33.6%) 
847 (35.8%) 
108 (4.6%) 
.168 
CRP1 (n=4304) 
Q1 [<.09] 
Q2 [.09-.23] 
Q3 [.23-.52] 
Q4 [>.52] 
 
 
2860 (60.7%) 
666 (14.1%) 
416 (8.8%) 
362 (7.7%) 
 
1209 (51.1%) 
306 (12.9%) 
231 (9.8%) 
207 (8.8%) 
.000 
BMI2 (n=4620) 
Underweight [<18.5] 
Normal [18.5-24.9] 
Overweight [25.0-29.9] 
Obese [30.0-34.9] 
Morbidly Obese [>35.0] 
 
 
661 (14.3%) 
2514 (54.4%) 
841 (18.2%) 
349 (7.6%) 
255 (5.5%) 
 
269 (12.6%) 
1111 (52.2%) 
372 (17.5%) 
223 (10.5%) 
154 (7.2%) 
.000 
DII3 (n=4504) 
Q1 [< -.82] 
Q2 [-.82-.32] 
Q3 [.32-1.25] 
Q4 [>1.25] 
 
 
1009 (22.4%) 
1155 (25.6%) 
1136 (25.2%) 
1204 (26.7%) 
 
467 (22.6%) 
526 (25.4%) 
526 (25.4%) 
551 (26.6%) 
.995 
Food Security4 – Child (n=4022) 
Unaffected 
Reduced Quality or Quantity 
Reduced Quality and Quantity 
Severely Reduced Quality and Quantity 
 
 
2995 (74.5%) 
299 (7.4%) 
626 (15.6%) 
102 (2.5%) 
 
1524 (75.9%) 
140 (7.0%) 
294 (14.6%) 
49 (2.4%) 
 
 
 
 
.670 
Food Security4 – Adult (n=4495) 
Full 
Marginal 
Low 
Very Low 
 
 
2969 (66.1%) 
588 (13.1%) 
552 (12.3%) 
386 (8.6%) 
 
1525 (66.7%) 
283 (12.4%) 
325 (14.2%) 
152 (6.7%) 
.007 
Food Security4 – Household (n=4495) 
Full 
Marginal 
Low 
Very Low 
 
2931 (65.2%) 
472 (10.5%) 
694 (15.4%) 
398 (8.9%) 
 
1502 (65.7%) 
240 (10.5%) 
363 (15.9%) 
180 (7.9%) 
.582 
1 C-reactive protein (CRP) is an inflammatory marker and has been linked to CVD and obesity (Barinas-Mitchell et al., 2001) 
2 Body-mass Index (BMI) was categorized per CDC guidelines 
3 Dietary inflammatory Index (DII) is based on 8 pro-inflammatory and 8 anti-inflammatory components to assess the inflammatory 
potential of dietary factors to provide a quantitative means for assessing the role of diet in relation to health outcomes (Kanauchi et al., 
2019).  
4 Food security was assessed using the US Food Security Survey Module (US FSSM). For further specifications see Methods (p. 15)
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Table 3 Demographics and Clinicopathological Factors of participants age 12-19 by ALT status in NHANES 2001-06 (n=4714) 
Split by Race/Ethnicity 
  Non-Hispanic White 
(n=1329) 
Non-Hispanic Black 
(n=1571) Hispanic (n=1629) Other (n=185) 
Variable  Normal n=3921 
High 
n=793 P-value 
Normal 
n=3921 
High 
n=793 P-value 
Normal 
n=3921 
High 
n=793 P-value 
Normal 
n=3921 
High 
n=793 P-value 
Sex 
Male (n= 
2412) 
564 
(84.3%) 
105 
(15.7%) 0.507 
676 
(81.3%) 
155 
(18.7%) 0.893 
670 
(82.6%) 
141 
(17.4%) 0.251 
88 
(87.1%) 
13 
(12.9%) 0.081 Female 
(n=2302) 
565 
(85.6%) 
95 
(14.4%) 
600 
(81.1%) 
140 
(18.9%) 
693 
(84.7%) 
125 
(15.3%) 
65 
(77.4%) 
19 
(22.6%) 
CRP1 
(n=4304) 
Q1 [<.09] 710 (84.9%) 
126 
(15.1%) 
0.84 
792 
(80.2%) 
195 
(19.8%) 
0.515 
775 
(83.8%) 
150 
(16.2%) 
0.536 
93 
(83%) 
19 
(17%) 
0.968 
Q2 [.09-.23] 156 (83.4%) 
31 
(16.6%) 
160 
(85.1%) 
28 
(14.9%) 
216 
(82.4%) 
46 
(17.6%) 
24 
(82.8%) 
5 
(17.2%) 
Q3 [.23-.52] 94 (83.9%) 
18 
(16.1%) 
110 
(84%) 
21 
(16%) 
130 
(82.3%) 
28 
(17.7%) 
12 
(80%) 3 (20%) 
Q4 [>.52] 64 (88.9%) 
8 
(11.1%) 
104 
(80%) 
26 
(20%) 
125 
(82.2%) 
27 
(17.8%) 6 (75%) 2 (25%) 
BMI2 
(n=4620) 
Underweight 
[<18.5] 
180 
(82.9%) 
37 
(17.1%) 
0.537 
165 
(81.3%) 
38 
(18.7%) 
0.525 
182 
(85%) 
32 
(15%) 
0.725 
25 
(92.6%) 
2 
(7.4%) 
0.559 
Normal 
[18.5-24.9] 
613 
(84.7%) 
111 
(15.3%) 
687 
(81.1%) 
160 
(18.9%) 
705 
(83.8%) 
136 
(16.2%) 
81 
(79.4%) 
21 
(20.6%) 
Overweight 
[25.0-29.9] 
188 
(87%) 
28 
(13%) 
203 
(79.3%) 
53 
(20.7%) 
285 
(84.6%) 
52 
(15.4%) 
27 
(84.4%) 
5 
(15.6%) 
Obese [30.0-
34.9] 
88 
(82.2%) 
19 
(17.8%) 
86 
(81.1%) 
20 
(18.9%) 
97 
(80.8%) 
23 
(19.2%) 
14 
(87.5%) 
2 
(12.5%) 
Morbidly 
Obese 
[>35.0] 
39 
(90.7%) 
4 
(9.3%) 
106 
(86.9%) 
16 
(13.1%) 
68 
(80%) 
17 
(20%) 4 (80%) 1 (20%) 
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  Non-Hispanic White 
(n=1329) 
Non-Hispanic Black 
(n=1571) Hispanic (n=1629) Other (n=185) 
Variable  Normal n=3921 
High 
n=793 P-value 
Normal 
n=3921 
High 
n=793 P-value 
Normal 
n=3921 
High 
n=793 P-value 
Normal 
n=3921 
High 
n=793 P-value 
DII3 
(n=4504) 
Q1 [< -
.82] 
270 
(85.2%) 
47 
(14.8%) 
0.98 
254 
(81.7%) 
57 
(18.3%) 
0.573 
298 
(87.1%) 
44 
(12.9%) 
0.027 
32 
(82.1%) 
7 
(17.9%) 
0.99 
Q2 [-.82-
.32] 
263 
(84.8%) 
47 
(15.2%) 
278 
(79.4%) 
72 
(20.6%) 
380 
(84.3%) 
71 
(15.7%) 
37 
(84.1%) 
7 
(15.9%) 
Q3 [.32-
1.25] 
275 
(85.4%) 
47 
(14.6%) 
319 
(83.3%) 
64 
(16.7%) 
305 
(79.2%) 
80 
(20.8%) 
38 
(82.6%) 
8 
(17.4%) 
Q4 [>1.25] 284 (84.3%) 
53 
(15.7%) 
368 
(80.5%) 
89 
(19.5%) 
305 
(85%) 
54 
(15%) 
43 
(84.3%) 
8 
(15.7%) 
Food 
Security4 
– Child 
(n=4022) 
Unaffected 821 (84.1%) 
155 
(15.9%) 
0.576 
741 
(80.8%) 
176 
(19.2%) 
0.861 
820 
(83.9%) 
157 
(16.1%) 
0.838 
102 
(81.6%) 
23 
(18.4%) 
0.309 
Reduced 
Quality or 
Quantity 
36 
(92.3%) 
3 
(7.7%) 
107 
(81.7%) 
24 
(18.3%) 
98 
(85.2%) 
17 
(14.8%) 
14 
(100%) 0 (0%) 
Reduced 
Quality 
and 
Quantity 
62 
(84.9%) 
11 
(15.1%) 
187 
(78.9%) 
50 
(21.1%) 
256 
(84.8%) 
46 
(15.2%) 
12 
(85.7%) 
2 
(14.3%) 
Severely 
Reduced 
Quality 
and 
Quantity 
9 
(81.8%) 
2 
(18.2%) 
39 
(78%) 
11 
(22%) 
31 
(79.5%) 
8 
(20.5%) 
2 
(100%) 0 (0%) 
Food 
Security4 
– Adult 
(n=4495) 
Full 887 (84.5%) 
163 
(15.5%) 
0.61 
735 
(81.4%) 
168 
(18.6%) 
0.732 
741 
(84.9%) 
132 
(15.1%) 
0.408 
116 
(81.1%) 
27 
(18.9%) 
0.651 
Marginal 70 (88.6%) 
9 
(11.4%) 
184 
(79.7%) 
47 
(20.3%) 
216 
(81.2%) 
50 
(18.8%) 
11 
(91.7%) 
1 
(8.3%) 
Low 54 (84.4%) 
10 
(15.6%) 
148 
(82.2%) 
32 
(17.8%) 
249 
(84.1%) 
47 
(15.9%) 
11 
(91.7%) 
1 
(8.3%) 
Very Low 63 (88.7%) 
8 
(11.3%) 
134 
(78.4%) 
37 
(21.6%) 
106 
(80.9%) 
25 
(19.1%) 
11 
(84.6%) 
2 
(15.4%) 
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  Non-Hispanic White 
(n=1329) 
Non-Hispanic Black 
(n=1571) Hispanic (n=1629) Other (n=185) 
Variable  Normal n=3921 
High 
n=793 P-value 
Normal 
n=3921 
High 
n=793 P-value 
Normal 
n=3921 
High 
n=793 P-value 
Normal 
n=3921 
High 
n=793 P-value 
Food 
Security4 – 
Household 
(n=4495) 
Full 884 (84.4%) 
163 
(15.6%) 
0.672 
719 
(81.6%) 
162 
(18.4%) 
0.834 
733 
(84.9%) 
130 
(15.1%) 
0.217 
113 
(80.7%) 
27 
(19.3%) 
0.487 
Marginal 61 (88.4%) 
8 
(11.6%) 
145 
(79.2%) 
38 
(20.8%) 
165 
(79.3%) 
43 
(20.7%) 
11 
(91.7%) 
1 
(8.3%) 
Low 69 (86.3%) 
11 
(13.8%) 
197 
(80.4%) 
48 
(19.6%) 
298 
(84.4%) 
55 
(15.6%) 
15 
(93.8%) 
1 
(6.3%) 
Very 
Low 
60 
(88.2%) 
8 
(11.8%) 
140 
(79.5%) 
36 
(20.5%) 
116 
(81.7%) 
26 
(18.3%) 
10 
(83.3%) 
2 
(16.7%) 
1 C-reactive protein (CRP) is an inflammatory marker and has been linked to CVD and obesity (Barinas-Mitchell et al., 2001) 
2 Body-mass Index (BMI) was categorized per CDC guidelines 
3 Dietary inflammatory Index (DII) is based on 8 pro-inflammatory and 8 anti-inflammatory components to assess the inflammatory potential of dietary factors to provide a quantitative means 
for assessing the role of diet in relation to health outcomes (Kanauchi et al., 2019).  
4 Food security was assessed using the US Food Security Survey Module (US FSSM). For further specifications see Methods (p. 15) 
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Table 4 Predictors of ALT Status in Participants age 12-19 in NHANES 2001-06 (n=4714) 
 Univariate Model 
OR (95% CI) 
Multivariate Model 
OR (95% CI) 
Sex 
Male (ref) 
Female 
 
 
1.00 
.951 (.816-1.11) 
 
1.00 
.98 (.82-1.17) 
Race/Ethnicity 
NHW (ref) 
NHB 
Hispanic  
Other 
 
 
1.00 
1.31 (1.07-1.59) 
1.10 (0.92-1.35) 
1.18 (0.78-1.78) 
 
1.00 
1.25 (1.00-1.57) 
.99 (.79-1.25) 
.98 (.61-1.58) 
CRP1 (n=4304) 
Q1 [<.09] 
Q2 [.09-.23] 
Q3 [.23-.52] 
Q4 [>.52] 
 
 
1.00 
.96 (.76-1.20) 
.98 (.74-1.23) 
1.02 (.76-1.36) 
 
1.00 
.94 (.72-1.22) 
.87 (.63-1.22) 
1.13 (.80-1.59) 
BMI2 (n=4620) 
Underweight [<18.5] 
Normal [18.5-24.9] 
Overweight [25.0-29.9] 
Obese [30.0-34.9] 
Morbidly Obese [>35.0] 
 
 
1.00 
1.04 (.83-1.31) 
.99 (.76-1.31) 
1.14 (.81-1.60) 
.89 (.59-1.33) 
 
1.00 
1.04 (.81-1.33) 
1.11 (.82-1.50) 
1.12 (.75-1.66) 
1.04 (.66-1.63) 
DII3 (n=4504) 
Q1 [< -.82] 
Q2 [-.82-.32] 
Q3 [.32-1.25] 
Q4 [>1.25] 
 
 
1.00 
1.13 (.90-1.43) 
1.17(.93-1.47) 
1.12 (.89-1.41) 
 
1.00 
1.23 (.95-1.59) 
1.31 (1.01-1.69) 
1.14 (.88-1.48) 
Food Security4 – Child (n=4022) 
Unaffected 
Reduced Quality or Quantity 
Reduced Quality and Quantity 
Severely Reduced Quality and Quantity 
 
 
1.00 
.84 (.60-1.17) 
1.03 (.82-1.29) 
1.26 (.77-2.06) 
 
1.00 
.63 (.37-1.09) 
.89 (.51-1.54) 
1.04 (.47-2.29) 
Food Security4 – Adult (n=4495) 
Full 
Marginal 
Low 
Very Low 
 
 
1.00 
1.13 (.89-1.42) 
.99 (.77-1.26) 
1.16 (.88-1.53) 
 
1.00 
.58 (.22-1.51) 
.54 (.17-1.68) 
1.11 (.27-4.55) 
Food Security4 – Household (n=4495) 
Full 
Marginal 
Low 
Very Low 
 
1.00 
1.19 (.93-1.54) 
1.01 (.81-1.26) 
1.12 (.85-1.48) 
 
1.00 
2.08 (.80-5.41) 
2.03 (.53-7.75) 
1.26 (.23-6.75) 
1 C-reactive protein (CRP) is an inflammatory marker and has been linked to CVD and obesity (Barinas-Mitchell et al., 2001) 
2 Body-mass Index (BMI) was categorized per CDC guidelines 
3 Dietary inflammatory Index (DII) is based on 8 pro-inflammatory and 8 anti-inflammatory components to assess the inflammatory 
potential of dietary factors to provide a quantitative means for assessing the role of diet in relation to health outcomes (Kanauchi et al., 
2019).  
4 Food security was assessed using the US Food Security Survey Module (US FSSM). For further specifications see Methods (p. 15)  
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